Display Settings:

Format

Send to:

Choose Destination

    Semin Dial. 2004 Mar-Apr;17(2):142-5.

    Predicting treatment dose for novel therapies using urea standard Kt/V.

    Leypoldt JK, Jaber BL, Zimmerman DL.

    Research Service, Dialysis Program, VA Salt Lake City Health Care System, University of Utah, 85 N. Medical Drive East, Room 201, Salt Lake City, UT 84112-5350, USA. ken.leypoldt@hsc.utah.edu

    Calculation of urea standard Kt/V (stdKt/V) as a dose measure for guiding novel hemodialysis or hemofiltration therapy prescription is complex since this parameter depends on the magnitude of posttreatment urea rebound. We propose here a two-step procedure for calculating urea stdKt/V from single-pool urea Kt/V values (spKt/V) determined from serum urea concentrations in pretreatment and posttreatment blood samples. First, the dependence of urea stdKt/V on equilibrated Kt/V (eKt/V) was derived from a fixed-volume single-pool model. Second, an empirical equation for predicting urea eKt/V from urea spKt/V values was determined using multiple linear regression and available data during 4-hour hemodialysis, 2-hour hemodialysis, and 2-hour hemofiltration treatments. This empirical (rate/dose) equation is likely more robust for novel therapies than other equations derived from only data during conventional (4-hour) hemodialysis treatments. The combination of these formulas allowed construction of nomograms for calculating urea stdKt/V from spKt/V during novel therapies. These principles were further illustrated by calculating the predicted treatment dose for daily (six times per week) hemofiltration therapy required to achieve a given urea stdKt/V.

    PMID: 15043617 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read